001055489 Stock Overview
Operates as a medical technology company in Germany, rest of Europe, North America, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Carl Zeiss Meditec AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €174.60 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 1.04 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0.029% |
| 33 Year Change | 0.029% |
| 5 Year Change | 84.96% |
| Change since IPO | 572.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| 001055489 | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | 0% | -5.9% | -1.8% |
| 1Y | 0.03% | 13.1% | 6.1% |
Return vs Industry: 001055489 underperformed the Swiss Medical Equipment industry which returned 13.8% over the past year.
Return vs Market: 001055489 underperformed the Swiss Market which returned 6.1% over the past year.
Price Volatility
| 001055489 volatility | |
|---|---|
| 001055489 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in CH Market | 6.5% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: 001055489's share price has been volatile over the past 3 months compared to the Swiss market.
Volatility Over Time: Insufficient data to determine 001055489's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1846 | 4,950 | Markus Weber | www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir |
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Carl Zeiss Meditec AG Fundamentals Summary
| 001055489 fundamental statistics | |
|---|---|
| Market cap | CHF 4.89b |
| Earnings (TTM) | CHF 190.01m |
| Revenue (TTM) | CHF 1.93b |
25.7x
P/E Ratio2.5x
P/S RatioIs 001055489 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 001055489 income statement (TTM) | |
|---|---|
| Revenue | €2.07b |
| Cost of Revenue | €927.44m |
| Gross Profit | €1.14b |
| Other Expenses | €935.57m |
| Earnings | €203.20m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Dec 11, 2024
| Earnings per share (EPS) | 2.27 |
| Gross Margin | 55.11% |
| Net Profit Margin | 9.83% |
| Debt/Equity Ratio | 6.7% |
How did 001055489 perform over the long term?
See historical performance and comparison